10 June 2021 - Gilead Sciences announced today that the U.S. FDA has approved an expansion of the pediatric indication of ...
9 June 2021 - With this approval approximately 1,500 children with one minimal function mutation and one F508del mutation have a ...
1 June 2021 - Lannett today announced the U.S. FDA has accepted the abbreviated new drug application for fluticasone propionate and ...
1 June 2021 - Commercial launch planned for fourth quarter 2021. ...
13 May 2021 - Full U.S. commercial launch of Zynrelef is planned for July 2021. ...
15 April 2021 - Mayne Pharma Group and Mithra Pharmaceuticals are very pleased to announce that the US FDA has approved ...
12 April 2021 - Final FDA decision anticipated by 12 August. ...
31 March 2021 - Roszet is indicated for adults with primary non-familial hyperlipidaemia and homozygous familial hypercholesterolaemia. ...
30 March 2021 - Jazz Pharmaceuticals today announced that the U.S. FDA approved a revised label for Vyxeos (daunorubicin and ...
8 March 2021 - Milestone reinforces Viatris' commitment to complex products and innovative solutions to help increase patient access ...
2 March 2021 - KemPharm today announced that the U.S. FDA has approved the new drug application for Azstarys (formerly referred ...
2 March 2021 - Eyenovia today announced that the U.S. FDA has accepted the Company’s new drug application for MydCombi, ...
23 February 2021 - FDA PDUFA date is expected in December 2021. ...
24 February 2021 - ViiV Healthcare announced today the submission of a supplemental new drug application to the US FDA for ...
16 February 2021 - Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined ...